In-Depth Report Sheds Light on Distribution Deals in the Pharma and Biotech Sectors (2020–2025) A newly updated research publication, Distribution Deals in Pharmaceuticals and Biotechnology, offers a comprehensive analysis of distribution partnerships formed within the pharmaceutical and biotechnology industries from…
Gamma Delta T Cell Therapy: A Transformative Frontier in Cancer Immunotherapy with U.S. and China Leading Global Trials Gamma delta (γδ) T cell therapy is rapidly emerging as a promising frontier in the field of cancer immunotherapy. Unlike the more…
Acadia Pharmaceuticals Grants Equity Awards to New Hires Under Nasdaq Rule 5635(c)(4) Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system (CNS) disorders…
Manitoba Bioscience Association Backs Government Plan to Boost Research and Clinical Trials Bioscience Association Manitoba (BAM) has voiced strong support for a major new initiative from the Manitoba government aimed at advancing health research and clinical trials across the province.…
Stallergenes Greer Appoints CEOLIA as New Promotional Partner for Actair® in Japan, Concluding 13-Year Collaboration with Shionogi Stallergenes Greer, a global leader in allergen immunotherapy, has announced a strategic transition in the Japanese market for its flagship product, Actair®, a…
WHO Concludes Participation in Major Global Nuclear Emergency Simulation The World Health Organization (WHO) has successfully concluded its role in a high-stakes, 36-hour nuclear emergency simulation exercise organized by the International Atomic Energy Agency (IAEA). Known as ConvEx-3, this large-scale,…
Comprehensive Report Reveals Key Trends in Gynecology Collaboration and Licensing Deals from 2016 to 2025 Gynecology Collaboration and Licensing Deals report offers a deep dive into the evolving landscape of partnerships in women’s health, providing unparalleled insights into over 150…
Synedgen Appoints Dr. Laura Saward as CEO and Dr. Kenton Gregory as CMO Amid Strategic Growth Synedgen, Inc., a biotechnology company pioneering treatments based on human glycobiology, has announced significant leadership changes as the company accelerates its clinical and strategic…
Dyadic International Rebrands as Dyadic Applied BioSolutions, Marking Strategic Shift Toward Commercial Bioprocessing Solutions Dyadic International, Inc. (Nasdaq: DYAI), a global biotechnology company known for its proprietary gene expression platforms, has announced a strategic rebrand that reflects its evolution from…
Medimaps Group Launches Next-Generation TBS Osteo Software Across Europe to Revolutionize Osteoporosis Detection Medimaps Group S.A., a Swiss-based global leader in AI-powered bone health solutions, has announced the European launch of its next-generation TBS Osteo Advanced software, following its recent…
Novocure to Present Final PANOVA-3 Data Highlighting Pain and Quality of Life Benefits of TTFields Therapy in Pancreatic Cancer at ESMO GI 2025 Novocure (NASDAQ: NVCR) announced that it will present final secondary endpoint results from its pivotal Phase 3…
Sunshine Biopharma Launches NIOPEG® Biosimilar in Canada, Targeting $10B Biologics Market Sunshine Biopharma Inc. (NASDAQ: SBFM), a pharmaceutical company focused on developing and commercializing life-saving medicines across oncology, antiviral therapies, and other therapeutic areas, has announced the commercial launch of…